Advanced-Glycation Endproducts: How cross-linking properties affect the collagen fibril behavior
Source abstract
Abstract
Advanced-Glycation-Endproducts (AGEs) are known to be a major cause of impaired tissue material properties. In collagen fibrils, which constitute a major building component of human tissue, these AGEs appear as fibrillar cross-links. It has been shown that when AGEs accumulate in collagen fibrils, a process often caused by diabetes and aging, the mechanical properties of the collagen fibril are altered. However, current knowledge about the mechanical properties of different types of AGEs, and their quantity in collagen fibrils is limited owing to the scarcity of available experimental data. Consequently, the precise relationship between the nano-scale cross-link properties, which differ from type to type, their density in collagen fibrils, and the mechanical properties of the collagen fibrils at larger scales remains poorly understood. In our study, we use coarse-grained molecular dynamics simulations and perform destructive tensile tests on collagen fibrils to evaluate the effect of different cross-link densities and their mechanical properties on collagen fibril deformation and fracture behavior. We observe that the collagen fibril stiffens at high strain levels when either the AGEs density or the loading energy capacity of AGEs are increased. Based on our results, we demonstrate that this stiffening is caused by a mechanism that favors energy absorption via stretching rather than inter-molecular sliding. Hence, in these cross-linked collagen fibrils, the absorbed energy is stored rather than dissipated through friction, resulting in brittle fracture upon fibrillar failure. Further, by varying multiple AGEs nano-scale parameters, we show that the AGEs loading energy capacity is, aside from their density in the fibril, the unique factor determining the effect of different types of AGEs on the mechanical behavior of collagen fibrils. Our results show that knowing AGEs properties is crucial for a better understanding of the nano-scale origin of impaired tissue behavior. We further suggest that future experimental investigations should focus on the quantification of the loading energy capacity of AGEs as a key property for their influence on collagen fibrils.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Collagen: Extraction and Characterization · Bone and Dental Protein Studies · Advanced Glycation End Products research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Fatigue as the missing link between bone fragility and fracture10.1038/s41551-017-0183-9 ↗
2. Contributions of material properties and structure to increased bone fragility for a given bone mass in the UCD-T2DM rat model of type 2 diabetes10.1002/jbmr.3393 ↗
3. Andriotis · 2019
4. Atomistic and continuum modeling of mechanical properties of collagen: Elasticity, fracture, and self-assembly10.1557/jmr.2006.0236 ↗
5. Nature designs tough collagen: Explaining the nanostructure of collagen fibrils10.1073/pnas.0603216103 ↗
6. Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage10.1002/art.10627 ↗
7. Preferential sites for intramolecular glucosepane cross-link formation in type I collagen: A thermodynamic study10.1016/j.matbio.2015.06.001 ↗
8. Crippa · 2013
9. Influence of cross-link structure, density and mechanical properties in the mesoscale deformation mechanisms of collagen fibrils10.1016/j.jmbbm.2014.07.008 ↗
10. High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes10.1016/j.numecd.2017.06.014 ↗
11. Advanced glycation end-products reduce collagen molecular sliding to affect collagen fibril damage mechanisms but not stiffness10.1371/journal.pone.0110948 ↗
12. Advanced glycation endproducts and bone material strength in type 2 diabetes10.1210/jc.2016-1437 ↗
13. Advanced glycation end-products: Mechanics of aged collagen from molecule to tissue10.1016/j.matbio.2016.09.001 ↗
14. Age- and diabetes-related nonenzymatic crosslinks in collagen fibrils: Candidate amino acids involved in advanced glycation end-products10.1016/j.matbio.2013.09.004 ↗
15. Role of advanced glycation end products in cardiovascular disease
16. Collagen diversity, synthesis and assembly10.1007/978-0-387-73906-9_2 ↗
17. Altered tissue composition, microarchitecture, and mechanical performance in cancellous bone from men with type 2 diabetes mellitus10.1002/jbmr.3711 ↗
18. The multiple functions and mechanisms of osteopontin10.1016/j.clinbiochem.2018.07.003 ↗
19. The influence of AGEs and enzymatic cross-links on the mechanical properties of collagen fibrils
20. Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties
21. Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia10.1002/jbmr.5650110709 ↗
22. What is the function of osteocalcin?10.1016/j.job.2020.05.004 ↗
23. Dietary advanced glycation end-product consumption leads to mechanical stiffening of murine intervertebral discs
24. Advanced glycation end-products diminish tendon collagen fiber sliding10.1016/j.matbio.2013.01.003 ↗
25. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation10.1210/en.2002-220072 ↗
26. Effects of non-enzymatic glycation on the micro- and nano-mechanics of articular cartilage10.1016/j.jmbbm.2017.09.035 ↗
27. Crosslines a and B as candidates for the fluorophores in age- and diabetes-related cross-linked proteins, and their diacetates produced by maillard reaction of α-N-acetyl-L-lysine with D-glucose10.1039/C39920000992 ↗
28. Favored and disfavored pathways of protein crosslinking by glucose: Glucose lysine dimer (GLUCOLD) and crossline versus glucosepane10.1007/s00726-010-0631-2 ↗
29. Microfibrillar structure of type I collagen in situ10.1073/pnas.0502718103 ↗
30. Peppa · 2005 · 28
31. Perrone · 2020
32. LAMMPS molecular dynamics simulator10.1006/jcph.1995.1039 ↗
33. Advanced glycation end products in the pathogenesis of chronic kidney disease10.1016/j.kint.2017.11.034 ↗
34. Advanced glycation endproducts and bone material properties in type 1 diabetic mice10.1371/journal.pone.0154700 ↗
35. Effects of collagen crosslinking on bone material properties in health and disease10.1007/s00223-015-9985-5 ↗
36. Single-column high-performance liquid chromatographic–fluorescence detection of immature, mature, and senescent cross-links of collagen10.1006/abio.1997.2350 ↗
37. Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys10.1007/s00198-010-1454-4 ↗
38. Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy10.2337/diacare.24.3.479 ↗
39. Characterization of advanced glycation end products for biochemical studies: Side chain modifications and fluorescence characteristics10.1016/j.ab.2004.12.003 ↗
40. Glucosepane is a major protein cross-link of the senescent human extracellular matrix: Relationship with diabetes10.1074/jbc.M500733200 ↗
41. Failure of mineralized collagen fibrils: Modeling the role of collagen cross-linking10.1016/j.jbiomech.2008.02.017 ↗
42. Fracture mechanics of collagen fibrils: Influence of natural cross-links10.1016/j.bpj.2013.04.033 ↗
43. Effects of maturation and advanced glycation on tensile mechanics of collagen fibrils from rat tail and achilles tendons10.1016/j.actbio.2018.02.005 ↗
44. Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate10.1007/s00198-008-0754-4 ↗
45. Effects of non-enzymatic glycation on cancellous bone fragility10.1016/j.bone.2006.12.056 ↗
46. Osteopontin deficiency increases bone fragility but preserves bone mass10.1016/j.bone.2010.02.014 ↗
47. Advanced glycation end-products and bone fractures10.1138/20090390 ↗
48. Influence of nonenzymatic glycation on biomechanical properties of cortical bone10.1016/S8756-3282(00)00434-8 ↗
49. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage a possible mechanism through which age is a risk factor for osteoarthritis10.1002/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P ↗
50. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): An overview of their mechanisms of formation10.3109/10715762.2013.815348 ↗
51. Glycation increases human annulus fibrosus stiffness in both experimental measurements and theoretical predictions10.1016/j.jbiomech.2005.02.013 ↗
52. Causative or associative: A critical review of the role of advanced glycation end-products in bone fragility10.1016/j.bone.2022.116485 ↗
53. Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy10.1002/(SICI)1096-9136(199806)15:6<458::AID-DIA601>3.0.CO;2-Q ↗
54. Micromechanical analysis of native and cross-linked collagen type I fibrils supports the existence of microfibrils10.1016/j.jmbbm.2011.11.008 ↗
55. Human achilles tendon mechanical behavior is more strongly related to collagen disorganization than advanced glycation end-products content10.1038/s41598-021-03574-4 ↗
56. Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales10.1073/pnas.1107966108 ↗